BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29604339)

  • 1. Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior.
    Lu T; Yu C; Ni H; Liang W; Yan H; Jin W
    Int J Dev Neurosci; 2018 Jun; 67():46-50. PubMed ID: 29604339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of aggressive growth hormone secreting pituitary adenomas.
    Donoho DA; Bose N; Zada G; Carmichael JD
    Pituitary; 2017 Feb; 20(1):169-178. PubMed ID: 27987061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases.
    Chen M; Duan L; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
    Pituitary; 2023 Dec; 26(6):675-685. PubMed ID: 37847430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas.
    Takesue Y; Wei FY; Fukuda H; Tanoue Y; Yamamoto T; Chujo T; Shinojima N; Yano S; Morioka M; Mukasa A; Kuratsu J; Tomizawa K
    Endocr J; 2019 Sep; 66(9):807-816. PubMed ID: 31189758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.
    Pangal DJ; Wishart D; Shiroishi MS; Ruzevick J; Carmichael JD; Zada G
    Pituitary; 2022 Jun; 25(3):480-485. PubMed ID: 35334028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
    Shirian FI; Ghorbani M; Khamseh ME; Imani M; Panahi M; Alimohammadi A; Nourbakhsh M; Salimi V; Tavakoli-Yaraki M
    BMC Endocr Disord; 2021 Mar; 21(1):50. PubMed ID: 33736633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas.
    Yin H; Zheng X; Tang X; Zang Z; Li B; He S; Shen R; Yang H; Li S
    J Endocrinol Invest; 2021 Sep; 44(9):1947-1959. PubMed ID: 33559847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma.
    Zhang Y; Liu YT; Tang H; Xie WQ; Yao H; Gu WT; Zheng YZ; Shang HB; Wang Y; Wei YX; Wu ZR; Wu ZB
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6345-6356. PubMed ID: 31369093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.
    Wang J; Liu Q; Gao H; Wan D; Li C; Li Z; Zhang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317706203. PubMed ID: 28705113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
    Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
    Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y
    Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
    Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
    Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Cyclin E/Cdk2/p27
    Dong W; Zhu H; Gao H; Shi W; Zhang Y; Wang H; Li C; Song G; Zhang Y
    World Neurosurg; 2019 Jan; 121():e45-e53. PubMed ID: 30196178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
    He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
    Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion.
    Vazquez-Martinez R; Martinez-Fuentes AJ; Pulido MR; Jimenez-Reina L; Quintero A; Leal-Cerro A; Soto A; Webb SM; Sucunza N; Bartumeus F; Benito-Lopez P; Galvez-Moreno MA; Castaño JP; Malagon MM
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2269-76. PubMed ID: 18349058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.
    Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM
    Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
    Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
    Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.
    da Rocha AA; Giorgi RR; de Sa SV; Correa-Giannella ML; Fortes MA; Cavaleiro AM; Machado MC; Cescato VA; Bronstein MD; Giannella-Neto D
    Pituitary; 2006; 9(2):83-92. PubMed ID: 16832584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of PRDM2 involved the tumorigenesis of somatotroph adenomas through regulating c-Myc.
    Wei D; Yiyuan C; Qian L; Jianhua L; Yazhuo Z; Hua G
    Gene; 2020 May; 737():144456. PubMed ID: 32044406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.